Article Versions Notes

Karimi M, Osterlund P, Hammarström K, Imam I, Frodin J-E, Glimelius B. Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters. Cancers. 2022; 14(24):6238. https://doi.org/10.3390/cancers14246238

Karimi, Masoud, Pia Osterlund, Klara Hammarström, Israa Imam, Jan-Erik Frodin, and Bengt Glimelius. 2022. "Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters" Cancers 14, no. 24: 6238. https://doi.org/10.3390/cancers14246238

Karimi, M., Osterlund, P., Hammarström, K., Imam, I., Frodin, J.-E., & Glimelius, B. (2022). Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters. Cancers, 14(24), 6238. https://doi.org/10.3390/cancers14246238